Back to TARS
Janus Henderson Group Ltd. → TARS
Janus Henderson Group Ltd. TARS Position History
Tarsus Pharmaceuticals, Inc. • Healthcare
Quarters held
12
Latest value
$220.2M
Q3 2026
Peak value
$220.2M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $397K |
| Q4 2025 | $5M |
| Q4 2025 | $152.7M |
| Q1 2026 | $152.1M |
| Q1 2026 | $4.8M |
| Q1 2026 | $334K |
| Q1 2026 | $4.8M |
| Q1 2026 | $334K |
| Q1 2026 | $152.1M |
| Q3 2026 | $5.8M |
| Q3 2026 | $366K |
| Q3 2026 | $220.2M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $220.2M | 2.80M | — | — |
| Q3 2026 | $366K | 4.7K | — | — |
| Q3 2026 | $5.8M | 73.7K | — | — |
| Q1 2026 | $152.1M | 2.17M | — | — |
| Q1 2026 | $334K | 4.8K | — | — |
| Q1 2026 | $4.8M | 68.4K | — | — |
| Q1 2026 | $334K | 4.8K | — | — |
| Q1 2026 | $4.8M | 68.4K | — | — |
| Q1 2026 | $152.1M | 2.17M | — | — |
| Q4 2025 | $152.7M | 1.86M | — | — |
| Q4 2025 | $5M | 61.2K | — | — |
| Q4 2025 | $397K | 4.9K | — | — |
Other funds holding TARS
$299.3M
$273.9M
$273.1M
$252.5M
$234.7M
$230.8M
$211.3M